UK Medical Eligibility for Contraceptive Use 2016

Product Information

Which method works best for you depends on a number of factors, including your age, whether you smoke, your medical and family history, and any medicines you're taking. FSRH CEU Statement : New advice from the MHRA regarding cyproterone acetate: how does this affect prescribing of Co-cyprindiol/Dianette® for acne/hirsutism? July 2020 In line with the release of the 2016 UKMEC, we are launching this key guidance for nurses, which we hope will help them to make the most of the new tool, enabling them to identify which methods can safely be used by which women and when. progestogen-only injectables (depot medroxyprogesterone acetate (DMPA) and norethisterone enanthate (NET-EN)) and CHC are classed as UKMEC 3.

Find out more in Which method suits me? Where you can get contraception and emergency contraception You can start by finding out about the methods of contraception you can choose from, including how they work, who can use them and possible side effects. The UKMEC is a set of guidance criteria that enable and support clinicians to deliver safe, evidence-based contraceptive care to women.

Blogs

This authoritative, ‘go-to’ reference for clinicians provides contraceptives safely to women across the life course. Malaria (rarely seen) and Raynaud’s disease (reclassified) are among the conditions no longer included. What format is it available in? FSRH CEU Response to published study: Maternal use of hormonal contraception and risk of childhood leukemia: a nationwide, populate-based cohort study (September 2018) For women with obesity (BMI categories of >=30-34 kg/m2 and >=35 kg/m2) without coexistent medical conditions

A woman who has had a stroke in the past can generally start and use the progestogen only pill (UKMEC 2 - Initiation) but if she has a stroke while already using it this becomes a UKMEC 3 for Continuation and would require expert clinical management. What does it not do? It aims to give practical information to everyone who wants to know more about contraception, or who may have a question about the method they use or are thinking about using.Contraception is free on the NHS. Find out where to get contraception and search by postcode to find:

New conditions have been added to reflect population risk changes (bariatric surgery, organ transplant), increasingly recognised conditions (long QT syndrome) and rheumatoid arthritis.You can also find out where to get emergency contraception – the "morning after pill" or the IUD (coil). Common questions about contraception This Guidelines summary covers the key conditions that women commonly present with in a primary care setting. Please refer to the full guideline for evidence, clarifications, and additional comments associated with the recommendations. Aims of the UKMEC Guideline The first column indicates the condition. Each condition is defined as representing either an individual’s characteristics (for example age, parity) or a known pre-existing medical condition (for example diabetes, hypertension). Some conditions are subdivided to differentiate between varying degrees of the condition (for example migraine with or without aura).

A woman with current breast cancer would be a 4 for any hormonal method but it would be a 3 if she had breast cancer in the past. When an individual has multiple conditions all scoring UKMEC3 for a method, use of this method may pose an unacceptable risk; clinical judgement should be used in each individual case. Since its introduction, the UKMEC has become seen as the gold-standard for the safe prescribing of contraception. Anyone who provides contraception services should be familiar with it and have easy access to the summary sheets for everyday reference if seeing people for contraceptive care. For nurses this will most often be when seeing women for repeat pills and injectables. Alongside the method-specific guidance that the FSRH produces this supports clinicians in providing safe and up-to-date, evidence-based care to patients.This guidance provides evidence-based recommendations and good practice points for health professionals on the use of combined hormonal contraceptives (i.e. the combined oral contraceptive pill, transdermal patch and combined vaginal ring) currently available in the UK. It is intended for any health care professional or health service providing contraception or conception advice in the UK. This guidance provides evidence-based recommendations and good practice points for health professionals on the use of progestogen-only injectables (depot medroxyprogesterone acetate (DMPA), Depo-Provera) currently available in the UK. It is intended for any health care professional or health service providing contraception or conception advice in the UK. The guidance does not indicate a best method for a woman nor do they take into account efficacy (and this includes drug interactions or malabsorption).